Insider Buy/Sell Ratio — Last 3 Months
Ratio0.2:1
Daily Buy & Sell Volume
By Sector
Technology
Buys562
Sells11668
Buy $$8.23B
Sell $$13.15B
Ratio1:1.60
% Change vs. Prior
Ratio -61.2%Value -36.0%
Healthcare
Buys587
Sells4850
Buy $$306.36M
Sell $$11.57B
Ratio1:37.78
% Change vs. Prior
Ratio -38.0%Value -22.7%
Consumer Cyclical
Buys254
Sells2080
Buy $$92.45M
Sell $$5.77B
Ratio1:62.45
% Change vs. Prior
Ratio -96.6%Value +36.2%
Energy
Buys246
Sells437
Buy $$79.36M
Sell $$4.47B
Ratio1:56.31
% Change vs. Prior
Ratio -14.6%Value -26.4%
Industrials
Buys403
Sells1920
Buy $$323.99M
Sell $$4.21B
Ratio1:12.99
% Change vs. Prior
Ratio +55.6%Value -37.6%
Financial Services
Buys1075
Sells2902
Buy $$640.71M
Sell $$3.70B
Ratio1:5.78
% Change vs. Prior
Ratio -25.9%Value -3.1%
Consumer Defensive
Buys151
Sells654
Buy $$62.81M
Sell $$2.91B
Ratio1:46.30
% Change vs. Prior
Ratio -68.8%Value +42.7%
Communication Services
Buys131
Sells903
Buy $$185.57M
Sell $$1.19B
Ratio1:6.43
% Change vs. Prior
Ratio +243.4%Value +10.4%
Basic Materials
Buys151
Sells222
Buy $$39.53M
Sell $$358.75M
Ratio1:9.08
% Change vs. Prior
Ratio +12.8%Value -64.9%
Utilities
Buys56
Sells214
Buy $$27.63M
Sell $$240.91M
Ratio1:8.72
% Change vs. Prior
Ratio +1239.1%Value -96.0%
Real Estate
Buys190
Sells306
Buy $$32.13M
Sell $$212.13M
Ratio1:6.60
% Change vs. Prior
Ratio -48.6%Value -47.9%
By Industry
Hardware, Equipment & Parts
Buys18
Sells1245
Buy $$7.98B
Sell $$880.24M
Ratio9.07:1
% Change vs. Prior
Ratio -73.6%Value -56.7%
Medical - Instruments & Supplies
Buys18
Sells153
Buy $$1.65M
Sell $$3.79B
Ratio1:2293.25
% Change vs. Prior
Ratio -89.2%Value -50.7%
Biotechnology
Buys385
Sells2994
Buy $$260.21M
Sell $$3.51B
Ratio1:13.50
% Change vs. Prior
Ratio -57.2%Value +51.2%
Software - Application
Buys330
Sells2228
Buy $$191.08M
Sell $$2.70B
Ratio1:14.13
% Change vs. Prior
Ratio -80.5%Value +36.5%
Software - Infrastructure
Buys45
Sells3613
Buy $$9.23M
Sell $$2.88B
Ratio1:311.59
% Change vs. Prior
Ratio -76.1%Value -42.6%
Computer Hardware
Buys0
Sells2118
Buy $$0.00
Sell $$2.70B
RatioAll Sells
% Change vs. Prior
Ratio -100.0%Value +76.5%
Semiconductors
Buys123
Sells1479
Buy $$12.38M
Sell $$2.45B
Ratio1:197.69
% Change vs. Prior
Ratio +240.1%Value +7.2%
Oil & Gas Exploration & Production
Buys153
Sells92
Buy $$35.62M
Sell $$2.15B
Ratio1:60.48
% Change vs. Prior
Ratio +86.6%Value -40.0%
Specialty Retail
Buys71
Sells895
Buy $$25.98M
Sell $$2.10B
Ratio1:80.71
% Change vs. Prior
Ratio -87.6%Value +7.6%
Medical - Healthcare Information Services
Buys7
Sells331
Buy $$1.31M
Sell $$2.09B
Ratio1:1593.81
% Change vs. Prior
Ratio -97.0%Value +16.2%
Leisure
Buys27
Sells113
Buy $$7.65M
Sell $$1.27B
Ratio1:166.43
Aerospace & Defense
Buys39
Sells528
Buy $$2.60M
Sell $$1.17B
Ratio1:452.35
% Change vs. Prior
Ratio -81.8%Value -6.6%
Beverages - Non-Alcoholic
Buys14
Sells35
Buy $$2.78M
Sell $$1.17B
Ratio1:419.19
Asset Management
Buys322
Sells214
Buy $$134.17M
Sell $$890.36M
Ratio1:6.64
Financial - Capital Markets
Buys38
Sells464
Buy $$388.58M
Sell $$596.74M
Ratio1:1.54
Transactions (30740)
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
12,729
Price
$307.81
Total Value
$3.92M
Shares Held After
1,387,038
% of Holdings
0.9%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
1,348
Price
$307.09
Total Value
$413.96K
Shares Held After
1,399,767
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
480
Price
$305.87
Total Value
$146.82K
Shares Held After
1,401,115
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
400
Price
$304.89
Total Value
$121.96K
Shares Held After
1,401,595
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
247
Price
$303.17
Total Value
$74.88K
Shares Held After
1,401,995
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
593
Price
$302.25
Total Value
$179.23K
Shares Held After
1,402,242
% of Holdings
0.0%
ICHOR HOLDINGS, LTD. (ICHR)
BARROS PHILIP RYAN SR. — Director
Shares
13,705
Price
$70.19
Total Value
$961.95K
Shares Held After
165,078
% of Holdings
7.7%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
320
Price
$300.75
Total Value
$96.24K
Shares Held After
1,402,835
% of Holdings
0.0%
908 Devices Inc. (MASS)
Brown Christopher D. — Director
Shares
100
Price
$9.00
Total Value
$900.00
Shares Held After
875,459
% of Holdings
0.0%
Arteris, Inc. (AIP)
Viana Antonio J — Director
Shares
8,939
Price
$37.09
Total Value
$331.54K
Shares Held After
64,620
% of Holdings
12.2%
Arteris, Inc. (AIP)
Viana Antonio J — Director
Shares
7,000
Price
$36.51
Total Value
$255.56K
Shares Held After
73,559
% of Holdings
8.7%
Arteris, Inc. (AIP)
Viana Antonio J — Director
Shares
4,900
Price
$35.47
Total Value
$173.78K
Shares Held After
80,559
% of Holdings
5.7%
Pacira BioSciences, Inc. (PCRX)
WILLIAMS KRISTEN — Chief Administrative Officer
Shares
10,259
Price
$22.27
Total Value
$228.47K
Shares Held After
167,062
% of Holdings
5.8%
TJX COMPANIES INC /DE/ (TJX)
Herrman Ernie — Director
Shares
28,000
Price
$158.32
Total Value
$4.43M
Shares Held After
524,850
% of Holdings
5.1%
NovoCure Ltd (NVCR)
Leonard Frank X — Chief Executive Officer
Shares
34,273
Price
$17.93
Total Value
$614.63K
Shares Held After
459,520
% of Holdings
6.9%
California Resources Corp (CRC)
Bys Jay A. — EVP & Chief Commercial Officer
Shares
11,907
Price
$61.68
Total Value
$734.42K
Shares Held After
171,331
% of Holdings
6.5%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
1,000
Price
$12.80
Total Value
$12.80K
Shares Held After
21,969
% of Holdings
4.4%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
500
Price
$12.68
Total Value
$6.34K
Shares Held After
22,969
% of Holdings
2.1%
CG Oncology, Inc. (CGON)
POST LEONARD E — Director
Shares
1,000
Price
$54.50
Total Value
$54.50K
Shares Held After
0
% of Holdings
100.0%
SmartRent, Inc. (SMRT)
Martell Frank — Director
Shares
20,000
Price
$1.19
Total Value
$23.73K
Shares Held After
3,185,266
% of Holdings
0.6%
ACM Research, Inc. (ACMR)
Wang David H — Director
Shares
826
Price
$87.91
Total Value
$72.61K
Shares Held After
802,708
% of Holdings
0.1%
ACM Research, Inc. (ACMR)
Wang David H — Director
Shares
8,581
Price
$87.13
Total Value
$747.66K
Shares Held After
803,534
% of Holdings
1.1%
ACM Research, Inc. (ACMR)
Wang David H — Director
Shares
10,992
Price
$86.07
Total Value
$946.08K
Shares Held After
812,115
% of Holdings
1.3%
ACM Research, Inc. (ACMR)
Wang David H — Director
Shares
17,543
Price
$85.11
Total Value
$1.49M
Shares Held After
823,107
% of Holdings
2.1%
ACM Research, Inc. (ACMR)
Wang David H — Director
Shares
2,060
Price
$83.86
Total Value
$172.75K
Shares Held After
840,650
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
120
Price
$550.48
Total Value
$66.06K
Shares Held After
18,876
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,298
Price
$549.06
Total Value
$712.68K
Shares Held After
18,996
% of Holdings
6.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,749
Price
$548.04
Total Value
$1.51M
Shares Held After
20,294
% of Holdings
11.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,033
Price
$547.00
Total Value
$565.05K
Shares Held After
23,043
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,129
Price
$545.89
Total Value
$616.31K
Shares Held After
24,076
% of Holdings
4.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,545
Price
$544.94
Total Value
$841.94K
Shares Held After
25,205
% of Holdings
5.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,086
Price
$544.11
Total Value
$590.91K
Shares Held After
26,750
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
440
Price
$542.78
Total Value
$238.82K
Shares Held After
27,836
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
480
Price
$541.14
Total Value
$259.75K
Shares Held After
28,276
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
120
Price
$539.64
Total Value
$64.76K
Shares Held After
28,756
% of Holdings
0.4%
Xeris Biopharma Holdings, Inc. (XERS)
HALKUFF DAWN — Director
Shares
20,000
Price
$6.09
Total Value
$121.89K
Shares Held After
95,000
% of Holdings
17.4%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
4,104
Price
$34.67
Total Value
$142.29K
Shares Held After
211,930
% of Holdings
1.9%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
25,896
Price
$34.01
Total Value
$880.72K
Shares Held After
216,034
% of Holdings
10.7%
Xeris Biopharma Holdings, Inc. (XERS)
JOHNSON JOHN — Director
Shares
15,000
Price
$6.09
Total Value
$91.42K
Shares Held After
683,083
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$550.46
Total Value
$308.26K
Shares Held After
40,513
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
780
Price
$549.24
Total Value
$428.41K
Shares Held After
41,073
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,676
Price
$548.26
Total Value
$918.89K
Shares Held After
41,853
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,525
Price
$547.53
Total Value
$834.98K
Shares Held After
43,529
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,202
Price
$546.14
Total Value
$656.46K
Shares Held After
45,054
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,186
Price
$545.18
Total Value
$646.59K
Shares Held After
46,256
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,470
Price
$544.24
Total Value
$800.04K
Shares Held After
47,442
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
396
Price
$543.11
Total Value
$215.07K
Shares Held After
48,912
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
112
Price
$542.50
Total Value
$60.76K
Shares Held After
49,308
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
473
Price
$541.08
Total Value
$255.93K
Shares Held After
49,420
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$539.51
Total Value
$64.74K
Shares Held After
49,893
% of Holdings
0.2%
Showing 8801–8850 of 30740 transactions (page 177 of 615)